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Abstract
OBJECTIVE: Accumulation of advanced glycation
end products (AGEs) in the body due to the non-en-
zymatic glycation of proteins and oxidation is asso-
ciated with aging and diabetes mellitus. In this
study we wanted to investigate the antiglycation
and antioxidation potential of two medicinal
plants: Juglans regia and Calendula officinalis.
METHODS: In-vitro investigation was carried out to
discover the antiglycation and antioxidation poten-
tial of J. regia and C. officinalis. Using an Ultraviolet
Double-beam Spectrophotometer, we evaluated
the antiglycation property of the crude methanolic
extracts of J. regia and C. officinalis by assessing
their ability to inhibit the Maillard reaction. Employ-
ing the same instrument we also measured the an-
tioxidation potential of these plant extracts using
the nitric oxide (NO) free radical-scavenging assay.
RESULTS: J. regia had greater antiglycation ability,
with a minimum inhibitory concentration (MIC50) of
28 µg/mL as compared with that of C. officinalis
(270 µg/mL). C. officinalis had greater antioxidation
potential (26.10, 22.07 and16.06%at 0.5mg, 0.25mg
and 0.125 mg, respectively, as compared with
18.15, 16.50 and 16.06% of J. regia, respectively).
CONCLUSION: J. regia and C. officinalis inhibited
the Maillard reaction and prevented oxidation in-vi-
tro. Hence, the extracts of these plants could have
therapeutic uses in curbing chronic diabetic com-
plications and slowing down aging.
© 2012 JTCM. All rights reserved.
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INTRODUCTION
The Maillard reaction involves the non-enzymatic gly-
cation of proteins to form advanced glycation end
products (AGEs). Recent studies have shown that this
reaction involves not only non-enzymatic glycation but
also oxidation.1-3 Therefore, agents that have antiglyca-
tion and antioxidation properties could be used to pre-
vent this reaction.
In diabetes mellitus (DM), AGEs are formed at an ac-
celerated rate because of hyperglycemia.4,5 Accumula-
tion of AGEs in the heart, muscles and large blood ves-
sels results in the promotion and progression of diabet-
ic complications such as nephropathy, neuropathy, car-
diovascular disease and atherosclerosis.6-10 Therefore,
any drugs or agents that could stop the formation of
AGEs could be of therapeutic value.
Glycation of proteins and their further oxidation alters
their conformation and stability. It also induces the ag-
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gregation and immobilization of proteins through
crosslinkage.4,5,11 Collagen elasticity is responsible for
the shape of the human body. Glycation results in a
loss of collagen elasticity, leading to arterial stiffness
that decreases myocardial compliance and promotes ag-
ing.12,13
One of the ways to reduce the risk of diabetic complica-
tions and to slow down aging is to stop glycation and
oxidation processes. This is possible by using com-
pounds or agents that have antiglycation and antioxida-
tion properties. Plants have been major sources of
drugs worldwide and these drugs have few or no side
effects.14 On the Indian subcontinent, various plants
have been used to treat DM. Galenga officialis has
been used for DM treatment throughout history.15 It is
also believed by folk-medicine experts that plants such
as Berberis lycium have anti-ageing effects and keeps
the skin looking "fresh". Hence, in the present study
we tried to ascertain the antiglycation and antioxida-
tion effects of two commonly used plants: Juglans regia
and Calendula officinalis.
METHODS
Plant material
The bark of J. regia and the whole plant of C. officina-
lis were collected from Mardan, Pakistan. This was
kindly identified by Professor Abdur Rasheed (plant
taxonomist, Department of Botany, University of Pe-
shawar, Khyber Pukhtunkhwa, Pakistan).
Extraction
The bark of J. regia and whole plant of C. officinalis
were kept in a darkened room to dry, after which they
were chopped and ground to powder. Powdered fruits
(250 g) were soaked in methanol for 15 days (twice) at
room temperature. Each time the mixture was filtered,
the filtrates were combined and concentrated to crude
methanolic extracts using a rotatory evaporator at 40°C.
Materials
Several materials were used for the in-vitro antiglyca-
tion assay. Bovine serum albumin (BSA), D-glucose, so-
dium dihydrogen phosphate (Na2HPO4), potassium di-
hydrogenphosphate (KH2PO4), sodium chloride (Na-
Cl) and potassium chloride (KCl) were obtained from
Merck Pakistan (Lahore, Pakistan), as were aminogua-
nidine and retinoid; trichloroacetic acid (TCA) was
from Sigma Pakistan (Lahore, Pakistan). Alkaline phos-
phate-buffered solution (PBS) (137 nM NaCl, 8.1 nM
Na2HPO4, 2.68 mM KCl, 1.47 mM KH2PO4) was pre-
pared in distilled water and its pH adjusted to 7.4 with
0.25 N NaOH.
The materials used for the nitric oxide (NO) free radi-
cal-scavenging assay were: sodium nitroprusside (Na2[Fe
(CN)5NO)·2H2O) (SNP), sulfanilic acid (SA) (0.33%
in 20% acetic acid), (N-(1-Napthyl) ethylenediamine
dihydrochloride) (NED) (0.1% in H2O) and phos-
phate buffer (10 mM, pH=7.4). These materials were
acquired from Sigma Pakistan (Lahore, Pakistan). An
Ultraviolet (UV) Double-beam Spectrophotometer
(UV-1800ENG240V) was from Shimadzu (Kyoto, Ja-
pan). Ascorbic acid (vitamin-C) was the positive con-
trol.
In-vitro glycation assay
The method of Matsuura et al. 200216 was followed
with slight modifications. Stock solutions of plant ex-
tracts were prepared by dissolving 3 mg in 1 mL of al-
kaline PBS. From the stock solution, 10, 50, 90, and
130 µL solutions were taken using a micropipette and
were mixed with a solution containing 400 µg BSA
and 200 mM glucose. These reaction mixtures were
kept in a water bath at 55°C for 48 h. BSA and glucose
without any inhibitor was used as the control. After in-
cubation at 55° C for 48 h, the reaction mixture was
transferred into separate Effendorf tubes. Ten microli-
ters of 100 % w/v TCA was added and the mixture cen-
trifuged at 14,500 rpm for 4 min at 4°C. The superna-
tant was discarded and the pellet re-dissolved in 400
µL alkaline PBS.
Using the fully automated UV Double-beam Spectro-
photometer the degree of absorbance for the control
and test reaction mixtures was measured at 350 nm.
Percent inhibition was calculated using the following
formula:
Percent inhibition =[1–(As–Ao)/(Ab–Ao)] ×100
Where As is the absorbance of test samples, Ab is the ab-
sorbance of the reaction mixture without the plant ex-
tract and Ao is the absorbance of blank control.
NO free radical-scavenging assay
To carry out the NO free radical-scavenging assay, the
method of Ebrahimzadeh et al. 200917 was followed.
Briefly, stock solutions of test samples were prepared
by dissolving 3 mg of test samples into 1 mL of metha-
nol. Dilutions (0.5, 0.25 and 0.125 mg/mL) of test
samples were made from the stock solution, and 1 mL
of each introduced into separate test tubes along with 1
mL of SNP. This reaction mixture was then incubated
for 90 min at 27°C. After incubation, 0.5 mL of the re-
action mixture was added to 1 mL of SA and incubat-
ed at 27°C for 5 min. Then, 1 mL of NED was added
to it, and the mixture incubated for 30 min at 27°C.
Absorbance was measured at 546 nm. Methanol and vi-
tamin-C were used as the blank and positive control,
respectively. The percentage antioxidation potential
was calculated using the following formula:
Percent inhibition = (Ao–At/Ao) × 100
Where Ao is the absorbance of the control (reaction
mixture without extract) and At is the absorbance of
test samples.
RESULTS
Antiglycation assay
Spectrophotometric analyses of the test mixtures of J.
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regia and C. officinalis are shown in Figure 1. As the
concentration of the C. officinalis extract increased the
absorbance decreased, and reached a minimum of
0.012 nm at 390 µL. A similar trend was observed for
J. regia except for an unexpected rise in absorbance
from 270 µL to 390 µL. The minimum absorbance
(0.015 nm) for J. regia occurred at 270 µL.
MIC50 is the concentration at which 50% inhibition of
the reaction is observed. Hence, by calculating the con-
centration at which the absorbance (an indicator of the
Maillard reaction) decreased by 50% , we found that
aminoguanidine, J. regia and C. officinalis had MIC50
values of 70, 28, and 270 µg/mL, respectively (Figure
1). Figure 2 shows the percent inhibition of the Mail-
lard reaction by aminoguanidine and the two plant ex-
tracts versus the amount of test sample used.
NO free radical-scavenging assay
The antioxidation potentials of J. regia and C. officina-
lis were compared with that of ascorbic acid. Results
obtained from the NO scavenging assay are shown in
Table 1.
C. officinalis had more antioxidation potential than J.
regia but less than the standard at all concentrations
(Table 1). J. regia showed antioxidation potential at all
test concentrations but its percent antioxidation was
less than that of the standard and C. officinalis.
Table 1 Percent antioxidation activity of ascorbic acid, J. regia and C. officinalis at 0.5, 0.25 and 0.125 mg/mL
Test sample
Ascorbic acid
Juglans regia
Calendula officinalis
Percent antioxidation activity
0.5 mg/mL
26.50
18.15
26.10
0.25 mg/mL
26.28
16.50
22.07
0.125 mg/mL
24.34
16.06
16.17
DISCUSSION
There have been no antiglycation studies on J. Regia
and C. officinalis. This is the first study to report that
both have antiglycation potential. Our findings from
the antiglycation in-vitro assay showed that of the two,
J. Regia was a more effective antiglycation agent. We al-
so found that the percent inhibition of glycation was
concentration-dependent.
The results of the antioxidation study for J. Regia were
consistent with the findings from previous studies: J.
Regia has antioxidation potential. This signifies that
our findings are reliable and applicable for further re-
search.18 However, for C. officinalis, no antioxidation
study this is the first time that its antioxidation poten-
tial has been reported. We also compared the results for
the standard, J. Regia and C. officinalis. We found that
C. officinalis had greater antioxidation potential than
ascorbic Acid and J. Regia.
Glycation and oxidation reactions are vital to the com-
plications of DM and the progression of ageing. Our
results showed that the crude methanolic extracts of J.
Regia and C. officinalis could inhibit these two reac-
tions. Hence, we conclude that J. Regia and C. officina-
lis could have therapeutic potential against diabetic
complications and slowing down aging.
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